Tekla Capital Management LLC 89bio, Inc. Transaction History
Tekla Capital Management LLC
- $2.53 Billion
- Q2 2023
A detailed history of Tekla Capital Management LLC transactions in 89bio, Inc. stock. As of the latest transaction made, Tekla Capital Management LLC holds 105,898 shares of ETNB stock, worth $888,484. This represents 0.08% of its overall portfolio holdings.
Number of Shares
105,898
Previous 105,898
-0.0%
Holding current value
$888,484
Previous $1.61 Million
24.44%
% of portfolio
0.08%
Previous 0.06%
Shares
1 transactions
Others Institutions Holding ETNB
# of Institutions
172Shares Held
124MCall Options Held
78.7KPut Options Held
979K-
Janus Henderson Group PLC London, X016.5MShares$139 Million0.07% of portfolio
-
Ra Capital Management, L.P. Boston, MA14.2MShares$119 Million1.76% of portfolio
-
Suvretta Capital Management, LLC New York, NY10.2MShares$85.6 Million3.26% of portfolio
-
Rtw Investments, LP New York, NY7.48MShares$62.7 Million0.94% of portfolio
-
Black Rock Inc. New York, NY7.02MShares$58.9 Million0.0% of portfolio
About 89bio, Inc.
- Ticker ETNB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,484,500
- Market Cap $390M
- Description
- 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...